MAPK7 antibody (C-Term)
Quick Overview for MAPK7 antibody (C-Term) (ABIN2261971)
Target
See all MAPK7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 776-805, C-Term
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- ERK5, CT (Extracellular Signal-regulated Kinase 5, ERK-5, Big MAP Kinase 1, BMK1, BMK-1, Mitogen-activated Protein Kinase 7, MAP Kinase 7, MAPK 7, MAPK7, PRKM7)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 776-805 in the C-terminal region of human ERK5, UniProt #Q13164. Species sequence homology: mouse, rat, bovine
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
-
Alternative Name
- ERK5
-
UniProt
- Q13164
-
Pathways
- MAPK Signaling, Neurotrophin Signaling Pathway, Activation of Innate immune Response, cAMP Metabolic Process, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling
Target
-